Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients
Original Article
R.L. Gottlieb, C.E. Vaca, R. Paredes, J. Mera, B.J. Webb, G. Perez, G. Oguchi, P. Ryan, B.U. Nielsen, M. Brown, A. Hidalgo, Y. Sachdeva, S. Mittal, O. Osiyemi, J. Skarbinski, K. Juneja, R.H. Hyland, A. Osinusi, S. Chen, G. Camus, M. Abdelghany, S. Davies, N. Behenna-Renton, F. Duff, F.M. Marty, M.J. Katz, A.A. Ginde, S.M. Brown, J.T. Schiffer, and J.A. Hill
N Engl J Med 2022;386:305-315
Course summary
Available credit:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course opens:
01/26/2022
Course expires:
01/27/2024
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Saturday, January 27, 2024 - 11:59pm.

Facebook
X
LinkedIn
Forward